Premarket Decliner
NVCT Nuvectis Pharma7.00+0.20+2.9%
Premarket:6.00-1.00 (-14.3%)
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
Globe NewswireWed, 5-Feb 9:01 AM
NVCT Nuvectis Pharma10.67-0.31-2.8%
Premarket:7.35-3.32 (-31.1%)
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
Globe NewswireThu, 14-Nov 7:00 AM
